SELL YOUR PRODUCTS
*mymedicalexpo  
English
  • Products
  • Catalogs
  • News & Trends
  • Exhibitions

Hepatitis B test kit CapitalBio 300082
HBV

hepatitis B test kit
hepatitis B test kit
Add to favorites
Compare this product
 

Characteristics

Applications
hepatitis B
Micro-organism
HBV

Description

CapitalBio Genotype and Drug Resistance Detection Kit for Hepatitis B Virus The WHO identifies Hepatitis B as a major global health problem. According to the WHO, approximately 240 million individuals are chronically infected with hepatitis B. Each year, there are 780,000 deaths resulting from hepatitis B infection. CapitalBio Genotype and Drug Resistance Detection Kit for Hepatitis B Virus is designed for a rapid and accurate genotyping of subtypes of HBV and detection of drug resistance to four drugs and interferon. It employs multiplex asymmetric allele-specific PCR technology and covers 7 drug-resistance-related mutations. It helps to ensure correct diagnosis and effective treatment. Key Features ● High Throughput: The genotyping of three subtypes of HBV and the detection of drug resistance to four drugs and interferon are done simultaneously. ● Rapid Detection: It takes only 6 hours to finish the testing process. ● High Sensitivity: Its detection limit is 1×103 IU/mL. ● Automatic Operation: Hybridization, washing, and scanning are all finished by instruments. No developing operation is needed. Reports are generated automatically by the software. ● High Traceability: Test results can be saved permanently and therefore are highly traceable.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.